These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27594356)

  • 21. Levosimendan: a new option in acute cardiac failure.
    Holley AD; Ziegenfuss M
    Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period.
    Papadopoulou EF; Mavrogeni SI; Dritsas A; Cokkinos DV
    Hellenic J Cardiol; 2009; 50(4):269-74. PubMed ID: 19622496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a calcium sensitizer, levosimendan, in patients with right heart failure due to pulmonary hypertension.
    Jiang R; Zhao QH; Wu WH; Zhang R; Yuan P; Gong SG; He J; Luo CJ; Qiu HL; Wang L; Liu JM
    Clin Respir J; 2018 Apr; 12(4):1518-1525. PubMed ID: 28862394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripartum cardiomyopathy: a new successful setting for levosimendan.
    Benezet-Mazuecos J; de la Hera J
    Int J Cardiol; 2008 Jan; 123(3):346-7. PubMed ID: 17324479
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study.
    De Luca L; Sardella G; Proietti P; Battagliese A; Benedetti G; Di Roma A; Fedele F
    J Am Soc Echocardiogr; 2006 Feb; 19(2):172-7. PubMed ID: 16455421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facilitation of left ventricular function recovery post percutaneous coronary intervention by levosimendan.
    Qarawani D; Cohen A; Nahir M; Hasin Y
    Int J Cardiol; 2013 Sep; 168(1):237-42. PubMed ID: 23063476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure.
    Ikonomidis I; Parissis JT; Paraskevaidis I; Kourea K; Bistola V; Lekakis J; Filippatos G; Kremastinos DT
    Eur J Heart Fail; 2007 Dec; 9(12):1172-7. PubMed ID: 18062901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
    Tasal A; Erturk M; Uyarel H; Karakurt H; Bacaksiz A; Vatankulu MA; Turfan M; Sonmez O; Erdogan E; Ergelen M
    J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
    Sargento L; Brito D; Matias JS; Madeira H
    Rev Port Cardiol; 2007; 26(7-8):717-26. PubMed ID: 17939581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
    Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T
    Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and effectiveness of levosimendan in patients with predominant right heart failure.
    Poelzl G; Zwick RH; Grander W; Metzler B; Jonetzko P; Frick M; Ulmer H; Pachinger O; Roithinger FX
    Herz; 2008 Jul; 33(5):368-73. PubMed ID: 18773157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracoronary infusion of levosimendan to treat postpericardiotomy heart failure.
    Caimmi PP; Grossini E; Molinari C; Vacca G; Teodori G
    Ann Thorac Surg; 2006 Nov; 82(5):e33-4. PubMed ID: 17062205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure.
    Papanikolaou J; Tsolaki V; Makris D; Zakynthinos E
    Int J Cardiol; 2014 Oct; 176(3):1435-7. PubMed ID: 25147072
    [No Abstract]   [Full Text] [Related]  

  • 34. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
    Silvetti S; Nieminen MS
    Int J Cardiol; 2016 Jan; 202():138-43. PubMed ID: 26386941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
    Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY
    Cardiovasc Ther; 2013 Apr; 31(2):108-14. PubMed ID: 23490237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of levosimendan on right ventricular functions by using novel tissue Doppler derived indices in patients with ischaemic left ventricular failure.
    Alibaz-Oner F; Gurbuz OZ; Oner E; Yurdakul S; Erguney M
    Kardiol Pol; 2013; 71(10):1036-41. PubMed ID: 24197584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
    Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan. A promising future drug for refractory cardiac failure in children?
    Kushwah S; Kumar A; Sahana KS
    Indian Heart J; 2016 Apr; 68 Suppl 1(Suppl 1):S57-60. PubMed ID: 27056655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
    Jörgensen K; Bech-Hanssen O; Houltz E; Ricksten SE
    Circulation; 2008 Feb; 117(8):1075-81. PubMed ID: 18268152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A struggle to SURVIVE: to abandon or not to abandon levosimendan?
    Butler J; Giamouzis G; Giannakoulas G
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):401-2. PubMed ID: 17701453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.